Vireo Growth Inc · CSE:VREO
Vireo Growth — Canaccord Virtual Conference 2020
24 slides from Vireo Growth's conference presentation, Sep 30, 2020
Slide 1: Canaccord Virtual Conference
“ We are building the cannabis company of the future by bringing the best of science, medicine and Canaccord Virtual Conference engineering to the cannabis industry. September 30, 2020 CNSX: VREO OTCQX: VREOF Kyle Kingsley, M.D. Founder & CEO
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This document includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, referred to herein and which constitute “forward-lo
Slide 3: Key Investment Highlights
Key Investment Highlights • Scientific expertise differentiates as a core competency within the industry. • Focus on intellectual property development is driving compelling long-term opportunities. • Impressive track record of winning licenses through merit-based awards and minimal investment. • Ass
Slide 4: Vireo At A Glance: Key Statistics
Vireo At A Glance: Key Statistics 340+ 32 Employees Dispensary Licenses 11 Manufacturing Licenses Research Partnerships 8 10 $30M 12 States (1) FY19 Revenue Patents-Pending (1) Including Puerto Rico. 80M Addressable Market Population Hemp Licenses 2 4
Slide 5: Our Strategy to Maximize Stakeholder Value
Our Strategy to Maximize Stakeholder Value 01 Lead with Science in Everything We Do • Recruit Superior Scientific Talent 03 Create a Best-in-Class Consumer Experience • Delight All Demographics with Welcoming Retail • Empower Teams to Capture Next-Generation Dispensaries Opportunities • Augment Reta
Slide 6: Lead with Science in Everything We Do: Intellectual Property
Lead with Science in Everything We Do: Intellectual property creates monetizable partnership Vireo’s Intellectual Property Portfolio opportunities; preserves long-term product margins Short-Term Monetization (potential revenue generation in the next 12-24 months) Cannabis Moist Snuff Composition Mul
Slide 7: Lead with Science in Everything We Do: Physician Leadership
Lead with Science in Unmatched medical expertise within Everything We Do: the cannabis industry Our Physician Leadership CHIEF EXECUTIVE OFFICER CHIEF MEDICAL OFFICER DIRECTOR OF MEDICAL • Board-certified emergency • Board-certified family physician EDUCATION medicine physician and successful with o
Slide 8: Our Healthcare and Medical Research Partnerships
Lead with Science in Everything We Do: Our Healthcare and Medical Vireo’s medical research partnerships are helping secure cannabis’ future as a viable healthcare alternative Research Partnerships Exclusive agreement to study the Randomized trial of medical Study to evaluate cannabis use Study to ev
Slide 9: Optimize the MSO for Cash Flow: Our MSO Operating Footprint
Optimize the MSO for Cash Flow: A unique portfolio of assets widely regarded as one Our MSO Operating Footprint of the most attractive in the U.S. cannabis industry PA Transaction MN MA NY RI PA PA NV OH • Sale of grower/processor MD operations to Jushi announced June 22, 2020 • Total consideration
Slide 10: Optimize the MSO for Cash Flow: Our MSO Operating Footprint
Optimize the MSO for Cash Flow: A unique portfolio of assets widely regarded as one Our MSO Operating Footprint of the most attractive in the U.S. cannabis industry Core markets expected to transition to adult-use within the next 6-24 months Non-core markets are candidates for future development or
Slide 11: 1H20 Performance & Development Update
1H20 Performance & Development Update For the Six Months Ended June 30, • At the time of closing of the PAMS transaction on 2020 2019 $ Change % Change August 11, 2020, the Company had Retail: approximately $21.1 million in cash on hand. MN $ 7,731,019 $ 4,893,616 $ 2,837,403 58% NY 5,271,378 5,199,
Slide 12: Best-In-Class Consumer Experience: Our Retail Dispensaries
Best-In-Class Consumer Green Goods™ retail dispensaries are currently being introduced across Vireo’s geographic footprint Experience: Our Retail Dispensaries Customer experience is amplified by e-commerce and home delivery in select markets. Green Goods™ Retail Concept Caters to Complete Cannabis C
Slide 13: Augment Retail with Home Delivery & E-Commerce
Best-In-Class Consumer Experience: Augment Retail with Home Delivery & E-Commerce: Our Medical Marijuana Products Delivered in 3 Easy Steps 1 2 3 Order Online Track Your Delivery Accept Delivery Select from a wide We’ll keep you We’ll notify you a few array of medical updated on the minutes before y
Slide 14: Build Meaningful Brands on Products Backed by Science
Build Meaningful Brands on Products Backed by Science Pharmaceutical-grade Products Innovative soft gels that delivers Premium-grade cannabis Geared Toward Patients consistent and precise doses for handpicked, hand-packaged, and A micro dose of cannabis in a the desired effect. cured for extended ti
Slide 15: Pursue Opportunistic Growth
Pursue Opportunistic Growth Positioned to drive upside growth opportunities through these categories: Merit-Based License Cost-Effective Strategic Partnerships Awards M&A Activity • Vireo’s existing footprint was We will pursue M&A opportunities • Our IP portfolio and scientific primarily built thro
Slide 16: Appendix
VY | C eC e) APPENDIX f a
Slide 17: Corporate Timeline
Corporate Timeline 2014 2015 2017 2018 2019 December June April June January Awarded 1 of 2 Awarded 1 of only 5 vertically- Launched NYC & Long Island’s Raised $17MM in a Series Acquisition of RI License vertically integrated integrated licences in NY first-ever medical marijuana D Round licenses in
Slide 18: Executive Management Team
Executive Management Team Kyle Kingsley, M.D. – Chief Executive Officer Amber Shimpa – Chief Administrative Officer Dr. Kingsley is a board-certified emergency medicine physician, entrepreneur, and Amber serves as Chief Administrative Officer and has been with Vireo Health inventor. Dr. Kingsley has
Slide 19: Board of Directors
Board of Directors Kyle Kingsley, M.D. – Chief Executive Officer Amber Shimpa – Chief Administrative Officer Dr. Kingsley is a board-certified emergency medicine physician, entrepreneur, and Amber serves as Chief Administrative Officer and has been with Vireo Health inventor. Dr. Kingsley has a stro
Slide 20: Consolidated Statements of Loss and Comprehensive Loss
VIREO HEALTH INTERNATIONAL, INC. Three Months Ended Three Months Ended Consolidated Statements of Loss and CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS June 30, June 30, For the Three Months Ended June 30, 2020 a nd 2019 Comprehensive Loss (Una udited - Expressed i n Unit
Slide 21: Consolidated Statements of Financial Position
VIREO HEALTH INTERNATIONAL, INC. Consolidated Statements of Financial Position CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION As a t June 30, 2020 a nd December 31, 2019 June 30, December 31, (Una udited - Expressed i n United States Dollars) 2020 2019 ASSETS Current Assets Cash $5,
Slide 22: Consolidated Statements of Cash Flows
VIREO HEALTH INTERNATIONAL, INC. Six Months Ended Six Months Ended Consolidated Statements of Cash Flows CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS For the Si x Months Ended June 30, 2020 a nd 2019 June 30, June 30, (Una udited - Expressed i n United States Dollars) 2020 2019 Cash Flows
Slide 23: Reconciliation of IFRS to Non-IFRS Financial Measures
Reconciliation of IFRS to Non-IFRS Financial Measures Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Net loss (8,977,461) (1,872,457) (11,001,240) (5,319,214) Net fair value adjustments (11,381,880) (4,272,905) (19,150,373) (9,244,373) Listing expense - - - 3,464,613 Gain
Slide 24: Contact Us
Contact Us investor@vireohealth.com www.vireohealth.com